Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ≥1 Month to <4 Years With Partial-onset Seizures
Condition(s):Epilepsy With Partial-onset SeizuresLast Updated:July 1, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Epilepsy With Partial-onset SeizuresLast Updated:July 1, 2021Completed
Condition(s):Effect of Drug; Migraine DisordersLast Updated:March 21, 2024Completed
Condition(s):Migraine DisordersLast Updated:February 6, 2024Recruiting
Condition(s):Alcohol Use DisorderLast Updated:June 28, 2022Completed
Condition(s):EpilepsyLast Updated:March 22, 2022Recruiting
Condition(s):EpilepsyLast Updated:May 30, 2017Completed
Condition(s):Alzheimer Disease 3; EpilepsyLast Updated:August 4, 2023Recruiting
Condition(s):Neuropathic Pain; Neuropathy;Peripheral; Neuropathy, Painful; Neuropathy, Diabetic; NeuropathyLast Updated:February 16, 2023Terminated
Condition(s):Partial EpilepsiesLast Updated:July 17, 2018Completed
Condition(s):Partial Epilepsies; Partial Onset SeizuresLast Updated:July 17, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.